L30P (p.Leu30Pro) variant of NFE2L2 (Q16236)

L30P (p.Leu30Pro) in NFE2L2 (Q16236) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as conflicting interpretations in the context of not provided; Immunodeficiency, developmental delay, and hypohomocysteinemia. The available variant effect predictions contribute to a CATVariant prioritization score of 0.41 / 1.

L30P (p.Leu30Pro) variant details